期刊文献+

DAPK启动子区异常甲基化模式在白血病诊断分型中的价值分析

Analysis of the value of abnormal methylation pattern in the promoter region of DAPK in the diagnosis of leukemia
原文传递
导出
摘要 目的:探讨抑癌基因DAPK启动子区异常甲基化模式作为潜在肿瘤标志物在白血病诊断分型中的价值。方法:采取亚硫酸氢盐测序法(BSP)对白血病细胞株和正常人外周血白细胞中抑癌基因DAPK启动子的异常甲基化模式进行分析;利用甲基化特异性PCR法(MSP)检验DAPK基因异常甲基化模式对于白血病诊断的效能。结果:Jurkat、U937、HL-60 3种细胞株的甲基化水平和正常细胞株比较差异有统计学意义(χ~2=90.736,P<0.05;χ~2=67.493,P<0.05;χ~2=753.284,P<0.05),提示肿瘤细胞的甲基化水平远高于正常细胞,且HL-60细胞株中的DAPK基因甲基化水平显著高于Jurkat和U937细胞株。ANLL用MSP甲基化检测时特异度、准确度和灵敏度分别为100%(61/61)、82.9%(87/105)和58.7%(27/46),未发现白血病病理分型和MSP诊断之间的关系。结论:抑癌基因DAPK启动子区异常甲基化模式作为一种潜在肿瘤标志物,极大丰富了临床诊断白血病的方法,对于白血病的诊断分型有重要的临床意义。 Objective:To investigate the value of abnormal methylation pattern of DAPK promoter region in the promoter region of tumor suppressor gene as a potential tumor marker in the diagnosis of leukemia.Method:Take the sulfurous acid hydrogen salt sequencing(BSP)on leukemia cell lines and normal human peripheral blood leukocytes in inhibiting cancer gene DAPK promoter abnormal methylation patterns were analyzed;with a methylation specific PCR(MSP)inspection and DAPK gene methylation mode for performance diagnosis of leukemia.Result:Jurkat,U937,HL-60 three cell lines of methylation and significant difference compared with the normal cell lines(χ~2= 90.736,P0.05;χ~2= 67.493,P0.05;χ~2= 753.284,P0.05),indicating the level of methylation of tumor cells is much higher than normal cells,and HL 60 cell lines of DAPK gene methylation level was significantly higher than that of Jurkat and U937 cell lines.ANLL with MSP methylation detection specific degrees,accuracy and sensitivity was 100%(61/61),82.9%(87/105)and 58.7%(27/46),leukemia are not found in the relationship between the pathological classification and MSP diagnosis.Conclusion:As a potential tumor marker,the abnormal methylation pattern of DAPK promoter region of tumor suppressor gene is a potential tumor marker,which greatly enriches the methods of clinical diagnosis of leukemia,and has a very important clinical significance for the diagnosis of leukemia.
作者 阮红刚 赵铮 许腊梅 付潮鸿 RUAN Honggang;ZHAO Zheng;XU Lamei;FU Chaohong(Department of Clinical Laboratory,Dongfeng Hospital Attached to Hubei Medical College,Shiyan,442000,China;Operation Room,Dongfeng Hospital Attached to Hubei Medical College)
出处 《临床血液学杂志(输血与检验)》 CAS 2018年第4期592-595,共4页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
基金 2012年度省教育厅科研计划项目(No:D20122404)
关键词 白血病 抑癌基因 DNA甲基化 DAPK基因甲基化模式 启动子 leukemia anti-oncogene DNA methylation methylation pattern of DAPK gene promoter
  • 相关文献

参考文献2

二级参考文献14

  • 1Issa J P.DNA methylation as a therapeutic target in cancer[J].Clin Cancer Res, 2007,13 (6) : 1634-1637.
  • 2Ellis L,Atadja P W,Johnstone R W,Epigenetics in cancer: target- ing chromatin modifications[J].Mol Cancer Ther, 2009,8 ( 6 ) : 1409-1420.
  • 3Kaminskas E,Farrell A T,Wang Y C,et al.FDA drug approval sum- mary :azacytidine(5-azacytidine, vidaza) for injectable suspension[J].On- cologist,2005,10(3) : 176-182.
  • 4Fenaux P, Mufti G J, Hellstrooro-Lindberg E,et al.Efficacy of azac- itidine compared with that of conventional care regimens in the treat- ment of higher-risk royelodysplastic syndromes: a randomised,open-la- bel,phase 111 study[J].Lancet Oncol,2009,10(3) :223-232.
  • 5Liu Y, Johnson S M, Fedoriw Y, et aI.Expression of p 16INK4a pre- vents cancer and promotes aging in |ymphocytes[J].B|ood,2011,117(12) : 3257-3267.
  • 6Lin Y, Hupp T R,Stevens C.Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death[J]. FEBS J, 2010,277( 1 ) :48-57.
  • 7Qian J,Wang Y L,Lin J,et al.Aberrant methylation of the death- associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia[J].Eur J Haematol, 2009,82 (2) : 119-123.
  • 8Liu L, Gerson S L.Targeted modulation of MGMT:clinical implica- tions [J].Clin Cancer Res, 2006,12(2) : 328-331.
  • 9Sanchez-Abarca L I,Gutierrez-Cosio S,Santamarta C,et al.Im- munomodulatory effect of 5-azacytidine (5-azaC):potential role in the transplantation setting[J].Blood,2010,115( 1 ) : 107-121.
  • 10Glover A B,Leyland-Jones B.Biochemistry of azacytidine:a review [J].Cancer Treat Rep, 1987,71 (10) : 959-964.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部